![John Morgan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in John Morgan first degree
Entity | Entity type | Industry | |
---|---|---|---|
AQIX Ltd.
![]() AQIX Ltd. Pharmaceuticals: MajorHealth Technology Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay.
4
| Private Company | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Morgan via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
United Kingdom Department of Health & Social Care | General Government | Founder | |
University of London | College/University | Doctorate Degree | |
Organon Pharma (UK) Ltd.
![]() Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chairman | |
The Association of the British Pharmaceutical Industry
![]() The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | President | |
Kings’ College | Corporate Officer/Principal | ||
Cooper & Scully PC
![]() Cooper & Scully PC Miscellaneous Commercial ServicesCommercial Services Cooper & Scully PC is a litigation firm that handles trials, appeals and arbitrations. It offers appellate, business transactions, construction, employment, energy, health care, insurance, intellectual property, medical malpractice, products liability, professional liability and transportation. The company was founded by John A. Scully in 1993 and is headquartered in Dallas, TX. | Miscellaneous Commercial Services | Director/Board Member | |
Medicines & Healthcare Products Regulatory Agency | General Government | Director/Board Member | |
Pharmaceutical Industry Competitiveness Task Force | General Government | Founder | |
Parkinson's Disease Society of the United Kingdom
![]() Parkinson's Disease Society of the United Kingdom Miscellaneous Commercial ServicesCommercial Services The Parkinson's Disease Society of the United Kingdom is a non-profit organization that aims to support research on Parkinson's disease. The non-profit company is based in London, UK. The British company provides health information about Parkinson's for patients, caregivers, and family members. The organization also supports researchers to involve patients and the public in their work. The company offers a Parkinson's Learning Pathway for occupational therapists, physiotherapists, and speech and language therapists. The company was founded in 1969 by Mali Jenkins. Caroline Rassell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
UK Clinical Research Collaboration | Founder | ||
Cell Therapy Catapult Ltd.
![]() Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Ministerial Industry Strategy Group | Corporate Officer/Principal | ||
The Caltech Y | Director/Board Member |
Statistics
International
United Kingdom | 11 |
United States | 4 |
Switzerland | 2 |
United Arab Emirates | 2 |
Sectoral
Health Technology | 5 |
Government | 4 |
Commercial Services | 4 |
Consumer Services | 2 |
Operational
Corporate Officer/Principal | 9 |
Director/Board Member | 6 |
Founder | 4 |
Chief Executive Officer | 3 |
Chairman | 2 |
Most connected contacts
Insiders | |
---|---|
Vincent Lawton | 11 |
Douglas Rees | 4 |
Matthew Durdy | 3 |
Jenny Murray | 1 |
- Stock Market
- Insiders
- John Morgan
- Company connections